Correlation Between Unity Biotechnology and Atea Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Unity Biotechnology and Atea Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unity Biotechnology and Atea Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Unity Biotechnology and Atea Pharmaceuticals, you can compare the effects of market volatilities on Unity Biotechnology and Atea Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unity Biotechnology with a short position of Atea Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unity Biotechnology and Atea Pharmaceuticals.

Diversification Opportunities for Unity Biotechnology and Atea Pharmaceuticals

0.73

Correlation Coefficient

Unity Biotechnology  Atea Pharmaceuticals

Poor diversification

The 3 months correlation between Unity and Atea is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Unity Biotechnology and Atea Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atea Pharmaceuticals and Unity Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unity Biotechnology are associated (or correlated) with Atea Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atea Pharmaceuticals has no effect on the direction of Unity Biotechnology i.e., Unity Biotechnology and Atea Pharmaceuticals go up and down completely randomly.

Pair Corralation between Unity Biotechnology and Atea Pharmaceuticals

Considering the 90-day investment horizon Unity Biotechnology is expected to under-perform the Atea Pharmaceuticals. In addition to that, Unity Biotechnology is 5.06 times more volatile than Atea Pharmaceuticals. It trades about -0.3 of its total potential returns per unit of risk. Atea Pharmaceuticals is currently generating about 0.14 per unit of volatility. If you would invest  290.00  in Atea Pharmaceuticals on May 20, 2025 and sell it today you would earn a total of  60.00  from holding Atea Pharmaceuticals or generate 20.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	56.45%
Values	Daily Returns

Unity Biotechnology  vs.  Atea Pharmaceuticals

Unity Biotechnology

Risk-Adjusted Performance

Weakest

Over the last 90 days Unity Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in September 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Atea Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Atea Pharmaceuticals are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak forward indicators, Atea Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Unity Biotechnology and Atea Pharmaceuticals

The main advantage of trading using opposite Unity Biotechnology and Atea Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unity Biotechnology position performs unexpectedly, Atea Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will offset losses from the drop in Atea Pharmaceuticals' long position.

The idea behind Unity Biotechnology and Atea Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.